Subspecialty Program Information - Haematology

The University of Manitoba is affiliated with two teaching hospitals, the Health Sciences Centre (HSC) and St. Boniface General Hospital (SBGH).  The program is also affiliated with CancerCare Manitoba (CCMB) which has its sites on the campuses of the HSC and SBGH.  Although the Section of Haematology/Oncology is a combined section within the Department of Internal Medicine, clinical activities are separate between the two services.  Although the training programs are thus separate, the close administrative relationship makes it easy for us to offer an integrated program in both Haematology and Medical Oncology for candidates wishing to seek dual certification from the Royal College, and we would undertake to ensure funding for the third year of fellowship that would be required if you were interested in pursuing that avenue.  Both the Haematology and Medical Oncology programs are in a building phase, with active recruitment of faculty underway.

CLINICAL ROTATIONS

Clinical training in Adult Haematology is obtained on the inpatient and outpatient services of our institutions.  CancerCare Manitoba is unique among provincial cancer agencies in that its mandate encompasses all blood disorders, and accordingly all Haematology outpatient clinics, for both benign and malignant disorders, take place in the CCMB facilities.  This offers numerous practical advantages. 

Pediatrics:  Experience in Pediatric Haematology/Oncology is provided under the supervision of Dr. Sara Israels, Head of the Section of Pediatric Hematology/Oncology, with participation of Dr. David Eisenstat, Dr. Rochelle Yanofsky, Dr. Marlis Schroeder, Dr. Bonnie Cham, Dr. Jayson Stoffman, Dr. Geoff Cuvelier, and Dr. Donna Wall.  Inpatient services are provided in the provincial Children’s Hospital, part of the HSC complex, while outpatient activities take place in a unique children’s clinic facility at CCMB.  The University of Manitoba has a Royal College program in Pediatric Haematology/Oncology. 

Leukemia/BMT:  Experience in acute leukemia and blood and marrow transplant is provided by the inpatient and outpatient Leukemia/Bone Marrow Transplantation service, which is an amalgam of the Leukemia Program under the direction of Dr. Eric Bow and the Manitoba Blood and Marrow Transplant Program under the direction of Dr. Matthew Seftel, with participation of Dr. Morel Rubinger, Dr. David Szwajcer, Dr. Eric Bow, and Dr. Brent Schacter.  This service is an academic investigative unit which represents the major referral service for all adult patients with acute leukemia in the province of Manitoba, with inpatient services provided on a specialized closed unit at HSC.  The BMT program offers experience in adult marrow and peripheral blood stem cell transplantation, reduced intensity allografting and marrow autografting.  We have major research interests in infectious complications in leukemia and BMT patients.

Medical Oncology:  Experience in Medical Oncology is available on the hospital consult services at both HSC and SBGH and in the disease site specific outpatient clinics of CCMB.  The Medical Oncology program has been revitalized under the program direction of Dr. Piotr Czaykowski.

General Haematology:  Rotations will be undertaken on the clinical Hematology services at SBGH and HSC.  During these periods, you will attend outpatient clinics and see in-hospital consults at the respective hospitals.  Both are full service tertiary care hospitals, and between them provide all tertiary care services for a population of over one million.  HSC has 797 beds and SBGH 555 beds.  Both hospitals have a full array of medical wards, surgical specialties, and intensive care units; in addition, HSC has a busy high-risk obstetrics unit and SBGH has a family practice unit.  These wards generate a diversity of types of consultations encompassing the entire spectrum of consultive hematology.  Outpatient experience in benign hematology is available in the clinics of Dr. Majid Shojania and Dr. Catherine Moltzan (SBGH) and Dr. Donald Houston and Dr. David Szwajcer (HSC). 

Residents have a half day longitudinal outpatient clinic throughout the two years of their training, under supervision of one of the above faculty.  The resident functions as the primary consultant in this clinic, allowing him or her to gain experience in the natural history of haematological disorders and to gain skills in the independent management of patients.

LABORATORY TRAINING

The laboratory training is extensive, including four months in Haematopathology rotations, with Dr. Carmen Morales, Dr. Gaynor Williams, Dr. Thomas Fourie, Dr. Charles Musuka, and Dr. Kristine Roland in the Haematopathology Laboratory of the HSC; with Dr. Catherine Moltzan and the aforementioned hematopathologists in the clinical Hematology Laboratory at SBGH; with Dr. Gaynor Williams and Dr. Angelika Dawson in the Cytogenetics Laboratory; and with Dr. Carmen Morales in Flow Cytometry and Immunoprotein Laboratories.  One month is spent with Dr. Debra Lane in Transfusion Medicine at the Canadian Blood Services Transfusion Service, and one month with Dr. Sara Israels in the Hemostasis Laboratory (the provincial referral laboratory for special coagulation testing).  Additional time on any of these services can be arranged as suits the interests of our trainees.

ACADEMIC ACTIVITIES

Academic activities that you will be expected to participate in include weekly Medical Grand Rounds, weekly Section of Haematology/Medical Oncology Grand Rounds, an informal weekly case presentation-based Walk Rounds, biweekly Lymphoma Rounds, and a monthly joint Haematology Disease Site Group/Hemostasis Disorders Care Team meeting.  Fellows are expected to present cases frequently at the Walk Rounds and Lymphoma Rounds, and give formal presentations at least twice per year to the Section Grand Rounds.  A journal club is held monthly in conjunction with the Medical Oncology program, and has been very successful this year.  

A weekly academic half-day will cover the breadth of the curriculum in Hematology set out by the Royal College objectives of training.  The format of these sessions is dependent on the number of fellows in the program; when numbers allow, they are primarily resident-led, but faculty-supervised formal small group learning activities; if only a single Fellow is involved, they will take the form of one-on-one tutorials with assigned faculty members.

To address the Royal College’s CanMEDS competencies of Health Advocate, Manager, Collaborator, and Communicator, we have developed an Administrative Project Block of one month, during which you are expected to prepare (i) a submission to the Pharmacy and Therapeutics Committee at CCMB or one of the host hospitals, and (ii) develop or adapt for local use a clinical practice guideline for a relevant Disease Site Group at CancerCare Manitoba.

During the course of the two years of training we expect trainees to become involved with research projects either at the clinical or basic science levels.  An asset of our program is the close interaction between clinicians and basic scientists in the Manitoba Institute of Cell Biology (MICB), which is located within CCMB.  Many of the attending physicians in the Section have laboratory research programs of their own in the MICB, or collaborative projects with MICB scientists.  Areas of major interest in our institution include:  identification of molecular markers of prognostic significance; mechanisms of gene amplification and genomic instability in tumors; regulation of apoptosis; platelet granule proteins, and molecular mechanisms of thrombosis.   Participation of fellows in the CancerCare Manitoba Research Day and U of M Internal Medicine Resident Research Day are encouraged, with the hope that the strong prize-winning record of our trainees will continue.

Many of our trainees become involved in their own projects under the supervision of one or more of the attending faculty.  Initially trainees become involved with some of the ongoing projects under the supervision of one of the faculty but later develop projects according to their own interests with the support of their supervisor.  A third year, to allow development of greater skills in basic research, can be arranged for trainees who are interested.

 

Application Deadline:  August 15th of the year preceding program commencement.

Application Form:    PDF    Word

Program Dates:     Two year program from July 1st in year one until June 30th in year two.

Remuneration: Residents will be paid according to the Professional Association of Residents of Manitoba (PARIM) agreement concerning remuneration of residents commensurate with their number of years of post-graduate training.

 

Contact:
Dr. Catherine Moltzan 
Director, Haematology Subspecialty Training Program
Room GF336A, Health Sciences Centre
820 Sherbrook Street
Winnipeg, MB     R3A 1R9
Phone: (204) 787-1103
Fax: (204) 787-8632
mailto: mdfehr@exchange.hsc.mb.ca

 

 



Application Form

PDF     Word